Likewise, in June 2025, Biocon received regulatory approval in India for its injectable liraglutide in pre-filled pen and cartridge formats, expanding market access
This makes injections highly effective for pernicious anaemia and other malabsorption syndromes, including post-gastrectomy states, Crohn's disease affecting the terminal ileum, and certain medications that interfere with B12 uptake
Common side effects from the injections may include injection site irritation, gastrointestinal discomfort, headaches, and dizziness, but they tend to be mild and transient
Use of this product is therefore not intended to compensate for diagnosis, treatment, cure, or mitigation of medical conditions and must not substitute obtaining medical advice from a registered health professional for any health or health-related conditions.